Apple partners with Synchron to enable iPhone control via brain implants

Summary

Apple has partnered with Synchron, a brain-computer interface startup, to develop technology that lets users control iPhones using neural signals from an implanted device. Apple is outsourcing the R&D and FDA approval work to Synchron rather than building the implant itself.

Synchron's approach is less invasive than Neuralink's. Neuralink requires drilling a hole in the skull roughly the size of a quarter to place electrodes directly in the brain. Synchron uses a stent-like device inserted through a vein near the motor cortex, making the procedure closer to a blood draw than a surgery.

Apple has worked with Synchron on a new accessibility standard to decode brain signals and translate them into device commands. The company is positioning this as an accessibility tool for people with disabilities, consistent with its strategy of letting specialized hardware makers clear regulatory hurdles first. Apple used a similar playbook with AirPods, where the same noise-cancellation hardware that blocks sound can amplify it, allowing AirPods Pro to qualify as hearing aids under FDA rules.

The commercial potential is framed as an accessibility play, though the underlying technology could eventually enable broader uses. The possibility of brain implants optimized for gambling apps or dopamine feedback illustrates the stakes if these devices scale beyond medical contexts.

Synchron's Series A included DARPA funding, which signals serious government backing for the research while inviting social media skepticism about government involvement in neural implants.